A Phase I, Single-dose Study with SB206 in Healthy Japanese Adults

Phase 1

• Conditions: Molluscum contagiosum

• Registration Number: JPRN-jRCT2031220073
• Lead Sponsor: Tsubouchi Ichiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-19
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

1. Healthy Japanese adult males aged 20 to 40 years at the time of obtaining written informed consent
2. Subjects with a body mass index (BMI) of 18.5 to 25.0 at screening
3. Subjects who are considered by the investigator or subinvestigator as acceptable for inclusion in the study as judged from the results of observation and examination upon screening and hospitalization
4. Subjects who received full explanations regarding the objective of the study, details of the study and the study drug and provided voluntary written informed consent

Exclusion Criteria

1. Subjects with a history of drug allergy
2. Subjects with a history of food allergy
3. Subjects with a history of contact dermatitis, such as adhesive tape dermatitis, or mechanical urticaria
4. Subjects considered ineligible for the study by the investigator or subinvestigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Skin irritation